nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—AKR1C3—Bimatoprost—glaucoma	0.414	0.769	CbGbCtD
Naproxen—PTGS2—glaucoma	0.21	1	CbGaD
Naproxen—SLC22A6—Methazolamide—glaucoma	0.0285	0.0531	CbGbCtD
Naproxen—SLC22A6—Acetazolamide—glaucoma	0.0228	0.0424	CbGbCtD
Naproxen—CYP1A2—Betaxolol—glaucoma	0.0192	0.0357	CbGbCtD
Naproxen—CYP2C9—Diclofenamide—glaucoma	0.0152	0.0283	CbGbCtD
Naproxen—CYP2C9—Dorzolamide—glaucoma	0.0147	0.0273	CbGbCtD
Naproxen—CYP2C9—Methazolamide—glaucoma	0.0131	0.0244	CbGbCtD
Naproxen—CYP1A2—Clonidine—glaucoma	0.0105	0.0195	CbGbCtD
Naproxen—Nabumetone—PTGS2—glaucoma	0.000534	0.23	CrCbGaD
Naproxen—Carprofen—PTGS2—glaucoma	0.000509	0.219	CrCbGaD
Naproxen—Suprofen—PTGS2—glaucoma	0.000315	0.135	CrCbGaD
Naproxen—Fenoprofen—PTGS2—glaucoma	0.000271	0.117	CrCbGaD
Naproxen—Indomethacin—PTGS2—glaucoma	0.0002	0.0861	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—glaucoma	0.000177	0.0761	CrCbGaD
Naproxen—Ketoprofen—PTGS2—glaucoma	0.00016	0.0689	CrCbGaD
Naproxen—Ibuprofen—PTGS2—glaucoma	0.000158	0.0678	CrCbGaD
Naproxen—Gastrointestinal disorder—Pilocarpine—glaucoma	8.01e-05	0.000387	CcSEcCtD
Naproxen—Gastrointestinal pain—Travoprost—glaucoma	7.99e-05	0.000387	CcSEcCtD
Naproxen—Loss of consciousness—Clonidine—glaucoma	7.98e-05	0.000386	CcSEcCtD
Naproxen—Feeling abnormal—Brinzolamide—glaucoma	7.95e-05	0.000385	CcSEcCtD
Naproxen—Mental disorder—Betaxolol—glaucoma	7.95e-05	0.000385	CcSEcCtD
Naproxen—Constipation—Pilocarpine—glaucoma	7.93e-05	0.000384	CcSEcCtD
Naproxen—Pain—Pilocarpine—glaucoma	7.93e-05	0.000384	CcSEcCtD
Naproxen—Cough—Clonidine—glaucoma	7.92e-05	0.000383	CcSEcCtD
Naproxen—Sweating—Timolol—glaucoma	7.92e-05	0.000383	CcSEcCtD
Naproxen—Dizziness—Apraclonidine—glaucoma	7.92e-05	0.000383	CcSEcCtD
Naproxen—Malnutrition—Betaxolol—glaucoma	7.9e-05	0.000382	CcSEcCtD
Naproxen—Erythema—Betaxolol—glaucoma	7.9e-05	0.000382	CcSEcCtD
Naproxen—Urticaria—Dorzolamide—glaucoma	7.8e-05	0.000377	CcSEcCtD
Naproxen—Epistaxis—Timolol—glaucoma	7.79e-05	0.000377	CcSEcCtD
Naproxen—Body temperature increased—Dorzolamide—glaucoma	7.76e-05	0.000375	CcSEcCtD
Naproxen—Abdominal pain—Dorzolamide—glaucoma	7.76e-05	0.000375	CcSEcCtD
Naproxen—Tension—Betaxolol—glaucoma	7.75e-05	0.000375	CcSEcCtD
Naproxen—Sinusitis—Timolol—glaucoma	7.75e-05	0.000375	CcSEcCtD
Naproxen—Arthralgia—Clonidine—glaucoma	7.73e-05	0.000374	CcSEcCtD
Naproxen—Chest pain—Clonidine—glaucoma	7.73e-05	0.000374	CcSEcCtD
Naproxen—Abdominal pain—Travoprost—glaucoma	7.73e-05	0.000374	CcSEcCtD
Naproxen—Agranulocytosis—Timolol—glaucoma	7.71e-05	0.000373	CcSEcCtD
Naproxen—Anxiety—Clonidine—glaucoma	7.7e-05	0.000373	CcSEcCtD
Naproxen—Asthenia—Acetazolamide—glaucoma	7.68e-05	0.000372	CcSEcCtD
Naproxen—Dizziness—Bimatoprost—glaucoma	7.68e-05	0.000371	CcSEcCtD
Naproxen—Nervousness—Betaxolol—glaucoma	7.67e-05	0.000371	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.67e-05	0.000371	CcSEcCtD
Naproxen—Urticaria—Brinzolamide—glaucoma	7.67e-05	0.000371	CcSEcCtD
Naproxen—Feeling abnormal—Pilocarpine—glaucoma	7.64e-05	0.00037	CcSEcCtD
Naproxen—Discomfort—Clonidine—glaucoma	7.63e-05	0.000369	CcSEcCtD
Naproxen—Vomiting—Apraclonidine—glaucoma	7.61e-05	0.000368	CcSEcCtD
Naproxen—Muscle spasms—Betaxolol—glaucoma	7.6e-05	0.000368	CcSEcCtD
Naproxen—Gastrointestinal pain—Pilocarpine—glaucoma	7.58e-05	0.000367	CcSEcCtD
Naproxen—Hypersensitivity—Brimonidine—glaucoma	7.57e-05	0.000366	CcSEcCtD
Naproxen—Dry mouth—Clonidine—glaucoma	7.56e-05	0.000366	CcSEcCtD
Naproxen—Dermatitis—Apraclonidine—glaucoma	7.54e-05	0.000365	CcSEcCtD
Naproxen—Headache—Apraclonidine—glaucoma	7.5e-05	0.000363	CcSEcCtD
Naproxen—Confusional state—Clonidine—glaucoma	7.47e-05	0.000361	CcSEcCtD
Naproxen—Vision blurred—Betaxolol—glaucoma	7.45e-05	0.00036	CcSEcCtD
Naproxen—Rhinitis—Timolol—glaucoma	7.43e-05	0.00036	CcSEcCtD
Naproxen—Oedema—Clonidine—glaucoma	7.41e-05	0.000358	CcSEcCtD
Naproxen—Tremor—Betaxolol—glaucoma	7.4e-05	0.000358	CcSEcCtD
Naproxen—Hallucination—Timolol—glaucoma	7.38e-05	0.000357	CcSEcCtD
Naproxen—Asthenia—Brimonidine—glaucoma	7.37e-05	0.000357	CcSEcCtD
Naproxen—Infection—Clonidine—glaucoma	7.36e-05	0.000356	CcSEcCtD
Naproxen—Body temperature increased—Pilocarpine—glaucoma	7.33e-05	0.000355	CcSEcCtD
Naproxen—Abdominal pain—Pilocarpine—glaucoma	7.33e-05	0.000355	CcSEcCtD
Naproxen—Ill-defined disorder—Betaxolol—glaucoma	7.33e-05	0.000355	CcSEcCtD
Naproxen—Diarrhoea—Acetazolamide—glaucoma	7.33e-05	0.000355	CcSEcCtD
Naproxen—Rash—Bimatoprost—glaucoma	7.32e-05	0.000354	CcSEcCtD
Naproxen—Dermatitis—Bimatoprost—glaucoma	7.31e-05	0.000354	CcSEcCtD
Naproxen—Oedema peripheral—Timolol—glaucoma	7.3e-05	0.000353	CcSEcCtD
Naproxen—Anaemia—Betaxolol—glaucoma	7.3e-05	0.000353	CcSEcCtD
Naproxen—Shock—Clonidine—glaucoma	7.29e-05	0.000353	CcSEcCtD
Naproxen—Connective tissue disorder—Timolol—glaucoma	7.29e-05	0.000353	CcSEcCtD
Naproxen—Pruritus—Brimonidine—glaucoma	7.27e-05	0.000352	CcSEcCtD
Naproxen—Headache—Bimatoprost—glaucoma	7.27e-05	0.000352	CcSEcCtD
Naproxen—Nervous system disorder—Clonidine—glaucoma	7.26e-05	0.000351	CcSEcCtD
Naproxen—Thrombocytopenia—Clonidine—glaucoma	7.25e-05	0.000351	CcSEcCtD
Naproxen—Hypersensitivity—Dorzolamide—glaucoma	7.23e-05	0.00035	CcSEcCtD
Naproxen—Tachycardia—Clonidine—glaucoma	7.23e-05	0.00035	CcSEcCtD
Naproxen—Hypersensitivity—Travoprost—glaucoma	7.2e-05	0.000348	CcSEcCtD
Naproxen—Skin disorder—Clonidine—glaucoma	7.19e-05	0.000348	CcSEcCtD
Naproxen—Hyperhidrosis—Clonidine—glaucoma	7.16e-05	0.000346	CcSEcCtD
Naproxen—Visual impairment—Timolol—glaucoma	7.15e-05	0.000346	CcSEcCtD
Naproxen—Malaise—Betaxolol—glaucoma	7.13e-05	0.000345	CcSEcCtD
Naproxen—Nausea—Apraclonidine—glaucoma	7.11e-05	0.000344	CcSEcCtD
Naproxen—Hypersensitivity—Brinzolamide—glaucoma	7.11e-05	0.000344	CcSEcCtD
Naproxen—Vertigo—Betaxolol—glaucoma	7.1e-05	0.000343	CcSEcCtD
Naproxen—Syncope—Betaxolol—glaucoma	7.09e-05	0.000343	CcSEcCtD
Naproxen—Dizziness—Acetazolamide—glaucoma	7.08e-05	0.000343	CcSEcCtD
Naproxen—Anorexia—Clonidine—glaucoma	7.06e-05	0.000342	CcSEcCtD
Naproxen—Asthenia—Dorzolamide—glaucoma	7.04e-05	0.000341	CcSEcCtD
Naproxen—Asthenia—Travoprost—glaucoma	7.01e-05	0.000339	CcSEcCtD
Naproxen—Palpitations—Betaxolol—glaucoma	6.98e-05	0.000338	CcSEcCtD
Naproxen—Pruritus—Dorzolamide—glaucoma	6.94e-05	0.000336	CcSEcCtD
Naproxen—Loss of consciousness—Betaxolol—glaucoma	6.94e-05	0.000336	CcSEcCtD
Naproxen—Eye disorder—Timolol—glaucoma	6.93e-05	0.000335	CcSEcCtD
Naproxen—Asthenia—Brinzolamide—glaucoma	6.92e-05	0.000335	CcSEcCtD
Naproxen—Hypotension—Clonidine—glaucoma	6.92e-05	0.000335	CcSEcCtD
Naproxen—Pruritus—Travoprost—glaucoma	6.91e-05	0.000335	CcSEcCtD
Naproxen—Tinnitus—Timolol—glaucoma	6.91e-05	0.000335	CcSEcCtD
Naproxen—Cough—Betaxolol—glaucoma	6.89e-05	0.000334	CcSEcCtD
Naproxen—Nausea—Bimatoprost—glaucoma	6.89e-05	0.000334	CcSEcCtD
Naproxen—Cardiac disorder—Timolol—glaucoma	6.88e-05	0.000333	CcSEcCtD
Naproxen—Hypersensitivity—Pilocarpine—glaucoma	6.83e-05	0.000331	CcSEcCtD
Naproxen—Pruritus—Brinzolamide—glaucoma	6.83e-05	0.00033	CcSEcCtD
Naproxen—Vomiting—Acetazolamide—glaucoma	6.81e-05	0.000329	CcSEcCtD
Naproxen—Dizziness—Brimonidine—glaucoma	6.8e-05	0.000329	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Clonidine—glaucoma	6.75e-05	0.000327	CcSEcCtD
Naproxen—Angiopathy—Timolol—glaucoma	6.73e-05	0.000326	CcSEcCtD
Naproxen—Arthralgia—Betaxolol—glaucoma	6.73e-05	0.000325	CcSEcCtD
Naproxen—Chest pain—Betaxolol—glaucoma	6.73e-05	0.000325	CcSEcCtD
Naproxen—Myalgia—Betaxolol—glaucoma	6.73e-05	0.000325	CcSEcCtD
Naproxen—Diarrhoea—Dorzolamide—glaucoma	6.72e-05	0.000325	CcSEcCtD
Naproxen—Headache—Acetazolamide—glaucoma	6.71e-05	0.000325	CcSEcCtD
Naproxen—Anxiety—Betaxolol—glaucoma	6.7e-05	0.000324	CcSEcCtD
Naproxen—Insomnia—Clonidine—glaucoma	6.7e-05	0.000324	CcSEcCtD
Naproxen—Immune system disorder—Timolol—glaucoma	6.7e-05	0.000324	CcSEcCtD
Naproxen—Diarrhoea—Travoprost—glaucoma	6.69e-05	0.000324	CcSEcCtD
Naproxen—Mediastinal disorder—Timolol—glaucoma	6.68e-05	0.000323	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.68e-05	0.000323	CcSEcCtD
Naproxen—Asthenia—Pilocarpine—glaucoma	6.65e-05	0.000322	CcSEcCtD
Naproxen—Paraesthesia—Clonidine—glaucoma	6.65e-05	0.000322	CcSEcCtD
Naproxen—Discomfort—Betaxolol—glaucoma	6.65e-05	0.000322	CcSEcCtD
Naproxen—Arrhythmia—Timolol—glaucoma	6.62e-05	0.000321	CcSEcCtD
Naproxen—Dyspnoea—Clonidine—glaucoma	6.6e-05	0.00032	CcSEcCtD
Naproxen—Diarrhoea—Brinzolamide—glaucoma	6.6e-05	0.000319	CcSEcCtD
Naproxen—Somnolence—Clonidine—glaucoma	6.58e-05	0.000319	CcSEcCtD
Naproxen—Dry mouth—Betaxolol—glaucoma	6.58e-05	0.000318	CcSEcCtD
Naproxen—Pruritus—Pilocarpine—glaucoma	6.56e-05	0.000318	CcSEcCtD
Naproxen—Alopecia—Timolol—glaucoma	6.55e-05	0.000317	CcSEcCtD
Naproxen—Confusional state—Betaxolol—glaucoma	6.5e-05	0.000315	CcSEcCtD
Naproxen—Mental disorder—Timolol—glaucoma	6.5e-05	0.000314	CcSEcCtD
Naproxen—Dizziness—Dorzolamide—glaucoma	6.49e-05	0.000314	CcSEcCtD
Naproxen—Rash—Brimonidine—glaucoma	6.48e-05	0.000314	CcSEcCtD
Naproxen—Dermatitis—Brimonidine—glaucoma	6.47e-05	0.000313	CcSEcCtD
Naproxen—Dizziness—Travoprost—glaucoma	6.46e-05	0.000313	CcSEcCtD
Naproxen—Malnutrition—Timolol—glaucoma	6.45e-05	0.000312	CcSEcCtD
Naproxen—Erythema—Timolol—glaucoma	6.45e-05	0.000312	CcSEcCtD
Naproxen—Oedema—Betaxolol—glaucoma	6.45e-05	0.000312	CcSEcCtD
Naproxen—Headache—Brimonidine—glaucoma	6.44e-05	0.000312	CcSEcCtD
Naproxen—Decreased appetite—Clonidine—glaucoma	6.44e-05	0.000312	CcSEcCtD
Naproxen—Infection—Betaxolol—glaucoma	6.41e-05	0.00031	CcSEcCtD
Naproxen—Gastrointestinal disorder—Clonidine—glaucoma	6.39e-05	0.000309	CcSEcCtD
Naproxen—Fatigue—Clonidine—glaucoma	6.39e-05	0.000309	CcSEcCtD
Naproxen—Dizziness—Brinzolamide—glaucoma	6.38e-05	0.000309	CcSEcCtD
Naproxen—Nausea—Acetazolamide—glaucoma	6.36e-05	0.000308	CcSEcCtD
Naproxen—Diarrhoea—Pilocarpine—glaucoma	6.35e-05	0.000307	CcSEcCtD
Naproxen—Shock—Betaxolol—glaucoma	6.34e-05	0.000307	CcSEcCtD
Naproxen—Tension—Timolol—glaucoma	6.33e-05	0.000306	CcSEcCtD
Naproxen—Constipation—Clonidine—glaucoma	6.33e-05	0.000306	CcSEcCtD
Naproxen—Pain—Clonidine—glaucoma	6.33e-05	0.000306	CcSEcCtD
Naproxen—Nervous system disorder—Betaxolol—glaucoma	6.32e-05	0.000306	CcSEcCtD
Naproxen—Thrombocytopenia—Betaxolol—glaucoma	6.31e-05	0.000306	CcSEcCtD
Naproxen—Tachycardia—Betaxolol—glaucoma	6.29e-05	0.000305	CcSEcCtD
Naproxen—Nervousness—Timolol—glaucoma	6.27e-05	0.000303	CcSEcCtD
Naproxen—Skin disorder—Betaxolol—glaucoma	6.26e-05	0.000303	CcSEcCtD
Naproxen—Vomiting—Dorzolamide—glaucoma	6.24e-05	0.000302	CcSEcCtD
Naproxen—Hyperhidrosis—Betaxolol—glaucoma	6.23e-05	0.000302	CcSEcCtD
Naproxen—Rash—Dorzolamide—glaucoma	6.19e-05	0.000299	CcSEcCtD
Naproxen—Dermatitis—Dorzolamide—glaucoma	6.18e-05	0.000299	CcSEcCtD
Naproxen—Rash—Travoprost—glaucoma	6.16e-05	0.000298	CcSEcCtD
Naproxen—Dermatitis—Travoprost—glaucoma	6.16e-05	0.000298	CcSEcCtD
Naproxen—Headache—Dorzolamide—glaucoma	6.15e-05	0.000298	CcSEcCtD
Naproxen—Anorexia—Betaxolol—glaucoma	6.15e-05	0.000297	CcSEcCtD
Naproxen—Vomiting—Brinzolamide—glaucoma	6.14e-05	0.000297	CcSEcCtD
Naproxen—Dizziness—Pilocarpine—glaucoma	6.13e-05	0.000297	CcSEcCtD
Naproxen—Headache—Travoprost—glaucoma	6.12e-05	0.000296	CcSEcCtD
Naproxen—Nausea—Brimonidine—glaucoma	6.1e-05	0.000295	CcSEcCtD
Naproxen—Feeling abnormal—Clonidine—glaucoma	6.1e-05	0.000295	CcSEcCtD
Naproxen—Rash—Brinzolamide—glaucoma	6.08e-05	0.000294	CcSEcCtD
Naproxen—Vision blurred—Timolol—glaucoma	6.08e-05	0.000294	CcSEcCtD
Naproxen—Dermatitis—Brinzolamide—glaucoma	6.08e-05	0.000294	CcSEcCtD
Naproxen—Gastrointestinal pain—Clonidine—glaucoma	6.06e-05	0.000293	CcSEcCtD
Naproxen—Headache—Brinzolamide—glaucoma	6.05e-05	0.000293	CcSEcCtD
Naproxen—Hypotension—Betaxolol—glaucoma	6.03e-05	0.000292	CcSEcCtD
Naproxen—Angioedema—Timolol—glaucoma	5.9e-05	0.000285	CcSEcCtD
Naproxen—Vomiting—Pilocarpine—glaucoma	5.9e-05	0.000285	CcSEcCtD
Naproxen—Urticaria—Clonidine—glaucoma	5.88e-05	0.000285	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Betaxolol—glaucoma	5.87e-05	0.000284	CcSEcCtD
Naproxen—Body temperature increased—Clonidine—glaucoma	5.86e-05	0.000283	CcSEcCtD
Naproxen—Abdominal pain—Clonidine—glaucoma	5.86e-05	0.000283	CcSEcCtD
Naproxen—Rash—Pilocarpine—glaucoma	5.85e-05	0.000283	CcSEcCtD
Naproxen—Dermatitis—Pilocarpine—glaucoma	5.84e-05	0.000283	CcSEcCtD
Naproxen—Insomnia—Betaxolol—glaucoma	5.83e-05	0.000282	CcSEcCtD
Naproxen—Nausea—Dorzolamide—glaucoma	5.83e-05	0.000282	CcSEcCtD
Naproxen—Headache—Pilocarpine—glaucoma	5.81e-05	0.000281	CcSEcCtD
Naproxen—Nausea—Travoprost—glaucoma	5.81e-05	0.000281	CcSEcCtD
Naproxen—Vertigo—Timolol—glaucoma	5.8e-05	0.000281	CcSEcCtD
Naproxen—Paraesthesia—Betaxolol—glaucoma	5.79e-05	0.00028	CcSEcCtD
Naproxen—Syncope—Timolol—glaucoma	5.79e-05	0.00028	CcSEcCtD
Naproxen—Dyspnoea—Betaxolol—glaucoma	5.75e-05	0.000278	CcSEcCtD
Naproxen—Nausea—Brinzolamide—glaucoma	5.73e-05	0.000277	CcSEcCtD
Naproxen—Palpitations—Timolol—glaucoma	5.7e-05	0.000276	CcSEcCtD
Naproxen—Dyspepsia—Betaxolol—glaucoma	5.68e-05	0.000275	CcSEcCtD
Naproxen—Loss of consciousness—Timolol—glaucoma	5.67e-05	0.000275	CcSEcCtD
Naproxen—Cough—Timolol—glaucoma	5.63e-05	0.000273	CcSEcCtD
Naproxen—Decreased appetite—Betaxolol—glaucoma	5.61e-05	0.000271	CcSEcCtD
Naproxen—Hypertension—Timolol—glaucoma	5.57e-05	0.00027	CcSEcCtD
Naproxen—Gastrointestinal disorder—Betaxolol—glaucoma	5.57e-05	0.000269	CcSEcCtD
Naproxen—Fatigue—Betaxolol—glaucoma	5.56e-05	0.000269	CcSEcCtD
Naproxen—Pain—Betaxolol—glaucoma	5.51e-05	0.000267	CcSEcCtD
Naproxen—Constipation—Betaxolol—glaucoma	5.51e-05	0.000267	CcSEcCtD
Naproxen—Nausea—Pilocarpine—glaucoma	5.51e-05	0.000267	CcSEcCtD
Naproxen—Chest pain—Timolol—glaucoma	5.5e-05	0.000266	CcSEcCtD
Naproxen—Myalgia—Timolol—glaucoma	5.5e-05	0.000266	CcSEcCtD
Naproxen—Arthralgia—Timolol—glaucoma	5.5e-05	0.000266	CcSEcCtD
Naproxen—Anxiety—Timolol—glaucoma	5.48e-05	0.000265	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.46e-05	0.000264	CcSEcCtD
Naproxen—Hypersensitivity—Clonidine—glaucoma	5.46e-05	0.000264	CcSEcCtD
Naproxen—Discomfort—Timolol—glaucoma	5.43e-05	0.000263	CcSEcCtD
Naproxen—Dry mouth—Timolol—glaucoma	5.37e-05	0.00026	CcSEcCtD
Naproxen—Asthenia—Clonidine—glaucoma	5.31e-05	0.000257	CcSEcCtD
Naproxen—Feeling abnormal—Betaxolol—glaucoma	5.31e-05	0.000257	CcSEcCtD
Naproxen—Confusional state—Timolol—glaucoma	5.31e-05	0.000257	CcSEcCtD
Naproxen—Anaphylactic shock—Timolol—glaucoma	5.27e-05	0.000255	CcSEcCtD
Naproxen—Oedema—Timolol—glaucoma	5.27e-05	0.000255	CcSEcCtD
Naproxen—Pruritus—Clonidine—glaucoma	5.24e-05	0.000254	CcSEcCtD
Naproxen—Infection—Timolol—glaucoma	5.23e-05	0.000253	CcSEcCtD
Naproxen—Shock—Timolol—glaucoma	5.18e-05	0.000251	CcSEcCtD
Naproxen—Nervous system disorder—Timolol—glaucoma	5.17e-05	0.00025	CcSEcCtD
Naproxen—Urticaria—Betaxolol—glaucoma	5.12e-05	0.000248	CcSEcCtD
Naproxen—Skin disorder—Timolol—glaucoma	5.12e-05	0.000248	CcSEcCtD
Naproxen—Body temperature increased—Betaxolol—glaucoma	5.1e-05	0.000247	CcSEcCtD
Naproxen—Hyperhidrosis—Timolol—glaucoma	5.09e-05	0.000246	CcSEcCtD
Naproxen—Diarrhoea—Clonidine—glaucoma	5.07e-05	0.000245	CcSEcCtD
Naproxen—Anorexia—Timolol—glaucoma	5.02e-05	0.000243	CcSEcCtD
Naproxen—Hypotension—Timolol—glaucoma	4.92e-05	0.000238	CcSEcCtD
Naproxen—Dizziness—Clonidine—glaucoma	4.9e-05	0.000237	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Timolol—glaucoma	4.8e-05	0.000232	CcSEcCtD
Naproxen—Insomnia—Timolol—glaucoma	4.76e-05	0.000231	CcSEcCtD
Naproxen—Hypersensitivity—Betaxolol—glaucoma	4.75e-05	0.00023	CcSEcCtD
Naproxen—Paraesthesia—Timolol—glaucoma	4.73e-05	0.000229	CcSEcCtD
Naproxen—Vomiting—Clonidine—glaucoma	4.71e-05	0.000228	CcSEcCtD
Naproxen—Dyspnoea—Timolol—glaucoma	4.7e-05	0.000227	CcSEcCtD
Naproxen—Somnolence—Timolol—glaucoma	4.68e-05	0.000227	CcSEcCtD
Naproxen—Rash—Clonidine—glaucoma	4.67e-05	0.000226	CcSEcCtD
Naproxen—Dermatitis—Clonidine—glaucoma	4.67e-05	0.000226	CcSEcCtD
Naproxen—Headache—Clonidine—glaucoma	4.64e-05	0.000225	CcSEcCtD
Naproxen—Dyspepsia—Timolol—glaucoma	4.64e-05	0.000224	CcSEcCtD
Naproxen—Asthenia—Betaxolol—glaucoma	4.63e-05	0.000224	CcSEcCtD
Naproxen—Decreased appetite—Timolol—glaucoma	4.58e-05	0.000222	CcSEcCtD
Naproxen—Pruritus—Betaxolol—glaucoma	4.56e-05	0.000221	CcSEcCtD
Naproxen—Gastrointestinal disorder—Timolol—glaucoma	4.55e-05	0.00022	CcSEcCtD
Naproxen—Fatigue—Timolol—glaucoma	4.54e-05	0.00022	CcSEcCtD
Naproxen—Pain—Timolol—glaucoma	4.5e-05	0.000218	CcSEcCtD
Naproxen—Diarrhoea—Betaxolol—glaucoma	4.41e-05	0.000213	CcSEcCtD
Naproxen—Nausea—Clonidine—glaucoma	4.4e-05	0.000213	CcSEcCtD
Naproxen—Feeling abnormal—Timolol—glaucoma	4.34e-05	0.00021	CcSEcCtD
Naproxen—Gastrointestinal pain—Timolol—glaucoma	4.31e-05	0.000208	CcSEcCtD
Naproxen—Dizziness—Betaxolol—glaucoma	4.26e-05	0.000206	CcSEcCtD
Naproxen—Urticaria—Timolol—glaucoma	4.18e-05	0.000202	CcSEcCtD
Naproxen—ALB—Metabolism—CA5A—glaucoma	4.18e-05	0.000972	CbGpPWpGaD
Naproxen—ALB—Metabolism—NARFL—glaucoma	4.18e-05	0.000972	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CA1—glaucoma	4.17e-05	0.000971	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.17e-05	0.00097	CbGpPWpGaD
Naproxen—Body temperature increased—Timolol—glaucoma	4.16e-05	0.000202	CcSEcCtD
Naproxen—Abdominal pain—Timolol—glaucoma	4.16e-05	0.000202	CcSEcCtD
Naproxen—Vomiting—Betaxolol—glaucoma	4.1e-05	0.000198	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.07e-05	0.000948	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.07e-05	0.000948	CbGpPWpGaD
Naproxen—Rash—Betaxolol—glaucoma	4.07e-05	0.000197	CcSEcCtD
Naproxen—Dermatitis—Betaxolol—glaucoma	4.06e-05	0.000197	CcSEcCtD
Naproxen—SLCO1A2—Metabolism—CTSA—glaucoma	4.04e-05	0.000941	CbGpPWpGaD
Naproxen—Headache—Betaxolol—glaucoma	4.04e-05	0.000195	CcSEcCtD
Naproxen—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.02e-05	0.000936	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CA1—glaucoma	3.9e-05	0.000907	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.89e-05	0.000904	CbGpPWpGaD
Naproxen—Hypersensitivity—Timolol—glaucoma	3.88e-05	0.000188	CcSEcCtD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.87e-05	0.0009	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	3.84e-05	0.000895	CbGpPWpGaD
Naproxen—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.83e-05	0.000892	CbGpPWpGaD
Naproxen—Nausea—Betaxolol—glaucoma	3.83e-05	0.000185	CcSEcCtD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—glaucoma	3.82e-05	0.000889	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CA2—glaucoma	3.82e-05	0.000889	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—GSTM1—glaucoma	3.82e-05	0.000888	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HDAC9—glaucoma	3.81e-05	0.000886	CbGpPWpGaD
Naproxen—Asthenia—Timolol—glaucoma	3.78e-05	0.000183	CcSEcCtD
Naproxen—UGT1A1—Metabolism—CTSA—glaucoma	3.77e-05	0.000878	CbGpPWpGaD
Naproxen—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	3.77e-05	0.000876	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.73e-05	0.000868	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.73e-05	0.000868	CbGpPWpGaD
Naproxen—Pruritus—Timolol—glaucoma	3.73e-05	0.00018	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	3.66e-05	0.000851	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GSTT1—glaucoma	3.65e-05	0.000848	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.63e-05	0.000845	CbGpPWpGaD
Naproxen—Diarrhoea—Timolol—glaucoma	3.6e-05	0.000174	CcSEcCtD
Naproxen—UGT1A1—Metabolism—CA2—glaucoma	3.56e-05	0.000829	CbGpPWpGaD
Naproxen—Dizziness—Timolol—glaucoma	3.48e-05	0.000169	CcSEcCtD
Naproxen—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	3.46e-05	0.000806	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CA5A—glaucoma	3.42e-05	0.000796	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NARFL—glaucoma	3.42e-05	0.000796	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.42e-05	0.000795	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	3.39e-05	0.000788	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.39e-05	0.000788	CbGpPWpGaD
Naproxen—Vomiting—Timolol—glaucoma	3.35e-05	0.000162	CcSEcCtD
Naproxen—Rash—Timolol—glaucoma	3.32e-05	0.000161	CcSEcCtD
Naproxen—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.32e-05	0.000773	CbGpPWpGaD
Naproxen—Dermatitis—Timolol—glaucoma	3.32e-05	0.000161	CcSEcCtD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.31e-05	0.00077	CbGpPWpGaD
Naproxen—Headache—Timolol—glaucoma	3.3e-05	0.00016	CcSEcCtD
Naproxen—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.28e-05	0.000762	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CA1—glaucoma	3.18e-05	0.000739	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.14e-05	0.00073	CbGpPWpGaD
Naproxen—Nausea—Timolol—glaucoma	3.13e-05	0.000151	CcSEcCtD
Naproxen—ALB—Platelet degranulation—VEGFA—glaucoma	3.11e-05	0.000724	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—glaucoma	3.11e-05	0.000723	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.11e-05	0.000723	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.1e-05	0.000722	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—TXN—glaucoma	3.09e-05	0.000719	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CTSA—glaucoma	3.08e-05	0.000716	CbGpPWpGaD
Naproxen—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.06e-05	0.000713	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	3.05e-05	0.00071	CbGpPWpGaD
Naproxen—PTGS2—Disease—HEYL—glaucoma	3.01e-05	0.000701	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGFR1OP—glaucoma	3.01e-05	0.000701	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SMO—glaucoma	2.98e-05	0.000693	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	2.96e-05	0.000689	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.94e-05	0.000684	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CDKN2B—glaucoma	2.92e-05	0.00068	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NARFL—glaucoma	2.92e-05	0.00068	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CA5A—glaucoma	2.92e-05	0.00068	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CYP1B1—glaucoma	2.9e-05	0.000676	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CA2—glaucoma	2.9e-05	0.000676	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ABCA1—glaucoma	2.9e-05	0.000676	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.9e-05	0.000675	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.9e-05	0.000675	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.84e-05	0.000661	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.84e-05	0.000661	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TP53—glaucoma	2.74e-05	0.000638	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NTRK2—glaucoma	2.72e-05	0.000634	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—TXN—glaucoma	2.69e-05	0.000626	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.65e-05	0.000618	CbGpPWpGaD
Naproxen—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.62e-05	0.000609	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CA1—glaucoma	2.52e-05	0.000587	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—TXN—glaucoma	2.51e-05	0.000584	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.5e-05	0.000582	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—glaucoma	2.47e-05	0.000575	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.45e-05	0.000571	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MTHFR—glaucoma	2.45e-05	0.00057	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CTSA—glaucoma	2.44e-05	0.000568	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.43e-05	0.000566	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.41e-05	0.000562	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	2.41e-05	0.000561	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTT1—glaucoma	2.4e-05	0.000557	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB2—glaucoma	2.36e-05	0.000548	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NGFR—glaucoma	2.34e-05	0.000544	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GSTM1—glaucoma	2.32e-05	0.00054	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CA2—glaucoma	2.31e-05	0.000537	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.3e-05	0.000536	CbGpPWpGaD
Naproxen—AKR1C3—Disease—APOE—glaucoma	2.28e-05	0.000531	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CAV1—glaucoma	2.26e-05	0.000526	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.25e-05	0.000524	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.25e-05	0.000524	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NTRK1—glaucoma	2.22e-05	0.000517	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.13e-05	0.000495	CbGpPWpGaD
Naproxen—AKR1C3—Disease—BAD—glaucoma	2.13e-05	0.000495	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTT1—glaucoma	2.09e-05	0.000485	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—MTHFR—glaucoma	2.05e-05	0.000478	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CA1—glaucoma	2.05e-05	0.000477	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN2B—glaucoma	2.05e-05	0.000476	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TXN—glaucoma	2.05e-05	0.000476	CbGpPWpGaD
Naproxen—ALB—Metabolism—CA1—glaucoma	2.04e-05	0.000475	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CTSA—glaucoma	1.99e-05	0.000462	CbGpPWpGaD
Naproxen—ALB—Metabolism—CTSA—glaucoma	1.98e-05	0.00046	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EDN1—glaucoma	1.96e-05	0.000457	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTT1—glaucoma	1.95e-05	0.000453	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.92e-05	0.000446	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOE—glaucoma	1.91e-05	0.000445	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP1B1—glaucoma	1.91e-05	0.000444	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCA1—glaucoma	1.91e-05	0.000444	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CAV1—glaucoma	1.89e-05	0.00044	CbGpPWpGaD
Naproxen—PTGS2—Disease—HDAC9—glaucoma	1.88e-05	0.000437	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CA2—glaucoma	1.88e-05	0.000437	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.87e-05	0.000435	CbGpPWpGaD
Naproxen—ALB—Metabolism—CA2—glaucoma	1.87e-05	0.000434	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.85e-05	0.000431	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.83e-05	0.000427	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.83e-05	0.000427	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.82e-05	0.000424	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.82e-05	0.000424	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NGF—glaucoma	1.81e-05	0.00042	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SOD1—glaucoma	1.79e-05	0.000415	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—C3—glaucoma	1.72e-05	0.000399	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS3—glaucoma	1.71e-05	0.000398	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.68e-05	0.000391	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CA1—glaucoma	1.67e-05	0.000389	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCA1—glaucoma	1.66e-05	0.000387	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP1B1—glaucoma	1.66e-05	0.000387	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.64e-05	0.000382	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TXN—glaucoma	1.62e-05	0.000378	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CTSA—glaucoma	1.62e-05	0.000376	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOE—glaucoma	1.6e-05	0.000372	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTT1—glaucoma	1.59e-05	0.000369	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CAV1—glaucoma	1.58e-05	0.000368	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTGS2—glaucoma	1.56e-05	0.000364	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP1B1—glaucoma	1.55e-05	0.000361	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCA1—glaucoma	1.55e-05	0.000361	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CA2—glaucoma	1.53e-05	0.000355	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTM1—glaucoma	1.53e-05	0.000355	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—FN1—glaucoma	1.51e-05	0.000351	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.49e-05	0.000347	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.49e-05	0.000347	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—BAD—glaucoma	1.49e-05	0.000346	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.48e-05	0.000345	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CDKN1B—glaucoma	1.48e-05	0.000345	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.47e-05	0.000342	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.45e-05	0.000337	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NOS3—glaucoma	1.43e-05	0.000333	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CA1—glaucoma	1.43e-05	0.000332	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CTSA—glaucoma	1.38e-05	0.000322	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.38e-05	0.000321	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MMP1—glaucoma	1.36e-05	0.000317	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MTHFR—glaucoma	1.35e-05	0.000314	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTM1—glaucoma	1.33e-05	0.000309	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TXN—glaucoma	1.32e-05	0.000308	CbGpPWpGaD
Naproxen—ALB—Metabolism—TXN—glaucoma	1.31e-05	0.000306	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTGS2—glaucoma	1.31e-05	0.000305	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CAV1—glaucoma	1.31e-05	0.000304	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CA2—glaucoma	1.3e-05	0.000304	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.28e-05	0.000298	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.28e-05	0.000297	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.28e-05	0.000297	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCA1—glaucoma	1.26e-05	0.000294	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP1B1—glaucoma	1.26e-05	0.000294	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTT1—glaucoma	1.26e-05	0.000293	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOE—glaucoma	1.26e-05	0.000292	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CAV1—glaucoma	1.24e-05	0.000289	CbGpPWpGaD
Naproxen—ALB—Hemostasis—FN1—glaucoma	1.24e-05	0.000289	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTM1—glaucoma	1.24e-05	0.000289	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.21e-05	0.000281	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.2e-05	0.000279	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NOS3—glaucoma	1.2e-05	0.000279	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.2e-05	0.000278	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.19e-05	0.000277	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—glaucoma	1.17e-05	0.000273	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—glaucoma	1.1e-05	0.000255	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOE—glaucoma	1.09e-05	0.000254	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CAV1—glaucoma	1.08e-05	0.000252	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TXN—glaucoma	1.08e-05	0.00025	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1B—glaucoma	1.04e-05	0.000241	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTT1—glaucoma	1.02e-05	0.000239	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOE—glaucoma	1.02e-05	0.000237	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTT1—glaucoma	1.02e-05	0.000237	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTM1—glaucoma	1.01e-05	0.000235	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CAV1—glaucoma	1.01e-05	0.000235	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN2B—glaucoma	1.01e-05	0.000235	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCA1—glaucoma	1e-05	0.000234	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP1B1—glaucoma	1e-05	0.000234	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS3—glaucoma	9.87e-06	0.00023	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.82e-06	0.000228	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.73e-06	0.000226	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—glaucoma	9.6e-06	0.000223	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NOS3—glaucoma	9.4e-06	0.000219	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TXN—glaucoma	9.19e-06	0.000214	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—glaucoma	8.93e-06	0.000208	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—glaucoma	8.62e-06	0.000201	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—glaucoma	8.6e-06	0.0002	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—glaucoma	8.47e-06	0.000197	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.39e-06	0.000195	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTT1—glaucoma	8.34e-06	0.000194	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—glaucoma	8.32e-06	0.000194	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.31e-06	0.000193	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.26e-06	0.000192	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CAV1—glaucoma	8.24e-06	0.000192	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.22e-06	0.000191	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—glaucoma	8.19e-06	0.000191	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCA1—glaucoma	8.17e-06	0.00019	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP1B1—glaucoma	8.17e-06	0.00019	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCA1—glaucoma	8.12e-06	0.000189	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP1B1—glaucoma	8.12e-06	0.000189	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—glaucoma	8.02e-06	0.000187	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—glaucoma	7.88e-06	0.000183	CbGpPWpGaD
Naproxen—PTGS2—Disease—CAV1—glaucoma	7.81e-06	0.000182	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—glaucoma	7.64e-06	0.000178	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—glaucoma	7.49e-06	0.000174	CbGpPWpGaD
Naproxen—PTGS2—Disease—BAD—glaucoma	7.35e-06	0.000171	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTT1—glaucoma	7.13e-06	0.000166	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—glaucoma	7.11e-06	0.000165	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—glaucoma	7.09e-06	0.000165	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—glaucoma	6.99e-06	0.000163	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.73e-06	0.000157	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCA1—glaucoma	6.65e-06	0.000155	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP1B1—glaucoma	6.65e-06	0.000155	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—glaucoma	6.6e-06	0.000154	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAV1—glaucoma	6.54e-06	0.000152	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—glaucoma	6.53e-06	0.000152	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TP53—glaucoma	6.51e-06	0.000152	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—glaucoma	6.49e-06	0.000151	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—glaucoma	6.23e-06	0.000145	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—glaucoma	5.91e-06	0.000137	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—glaucoma	5.77e-06	0.000134	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.75e-06	0.000134	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—glaucoma	5.74e-06	0.000134	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—glaucoma	5.7e-06	0.000133	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP1B1—glaucoma	5.68e-06	0.000132	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCA1—glaucoma	5.68e-06	0.000132	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TP53—glaucoma	5.37e-06	0.000125	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—glaucoma	5.37e-06	0.000125	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—glaucoma	5.34e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAV1—glaucoma	5.32e-06	0.000124	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—glaucoma	5.31e-06	0.000124	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAV1—glaucoma	5.29e-06	0.000123	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1B—glaucoma	5.12e-06	0.000119	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—glaucoma	4.95e-06	0.000115	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—glaucoma	4.7e-06	0.000109	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—glaucoma	4.54e-06	0.000106	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—glaucoma	4.37e-06	0.000102	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAV1—glaucoma	4.33e-06	0.000101	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—glaucoma	4.02e-06	9.36e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—glaucoma	4.01e-06	9.34e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—glaucoma	4e-06	9.31e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—glaucoma	3.74e-06	8.69e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAV1—glaucoma	3.7e-06	8.61e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—glaucoma	3.68e-06	8.57e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—glaucoma	3.66e-06	8.52e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—glaucoma	3.28e-06	7.62e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—glaucoma	3e-06	6.97e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—glaucoma	2.8e-06	6.51e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—glaucoma	2.56e-06	5.96e-05	CbGpPWpGaD
